|
MISCARRIAGE
(SPONTANEOUS ABORTION)
1. Check JH,
Wu CH, Adelson HG: Decreased abortions in hMG induced pregnancies
with prophylactic progesterone therapy. Int J. Fertil 30:45-57,
1985. 
2. Check JH,
Rankin A, Teichman M: The risk of fetal anomalies as a result
of progesterone therapy during pregnancy. Fertil Steril 45(4):575-577,
1986.
3. Check JH,
Chase JS, Nowroozi K: Spontaneous abortion rate in patients with
endometriosis treated with progesterone. Int J Fertil 32:366-368,
1987.
4. Check JH,
Chase JS, Nowroozi K, Wu CH, Adelson HG: Progesterone therapy
to decrease first-trimester spontaneous abortions in previous aborters.
Int J Fertil 32:192-199, 1987.
5. Check JH,
Vaze M, Wu CH: Ineffectiveness of parenteral 17-hydroxyprogesterone
caproate. The AM J Gyn Health II(1):39-40, 1988.
6. Check JH,
Winkel CA, Check ML: Abortion rate in progesterone treated women
presenting initially with low first trimester serum progesterone
levels. The Am J Gyn Health IV(2)63/33-34/64, March-April 1990.
7. Check JH,
Nowroozi K, Vaze M, Wapner R, Seefried L: Very high CA-125 levels
during the early first trimester found in three cases spontaneously
aborting with chromosome abnormalities. Am J Obstet Gynecol
162:674-675, 1990.
8. Check JH,
Nowroozi K, Winkel CA, Johnson T, Seefried L: Serum CA-25 levels
in early pregnancy and subsequent spontaneous abortion. Obstet
Gynecol 75(5):742-744, 1990.
9. Check JH,
Vaze M. Epstein R, Wu CH, Quattrocchi, Vetter B: 17-hydroxyprogesterone
level as a marker for corpus luteum function in aborters versus
non-aborters. Int J. Fertil (35)2:112-115, 1990.
10. Check
JH, Vaze M, Vetter B: Measurement of placental protein 14 (PP14)
not helpful in predicting infertility or spontaneous abortion.
Int J. Fertil 38:34-36, 1993.
11. Check
JH: Letter to the editor: Serum CA-125 levels in early pregnancy
and subsequent spontaneous abortion. Obstet Gynecol 76:894-895,
1990.
12. Check
JH: Letter to the editor: Untreated luteal phase deficiency as
another possible factor for preterm delivery. Am J Obstet Gynecol
165:485-486, 1991.
13. Check
JH, Chase JS, Nowroozi K, Goldsmith G, Dietterich C: Evidence
that differences in sizes of fraternal twins may originate from
early gestation - A case report. Int J Fertil 37:165-166, 1992.
14. Nazari
A, Check JH, Epstein R, Dietterich C, Farzanfar S: Relationship
of small-for-dates sac size to crown-rump length and spontaneous
abortion in patients with a known date of ovulation. Obstet
Gynecol 78(3)369-373, 1991.
15. Check
JH, Nowroozi K, Vetter B, Rankin A, Dietterich C, Schubert B: The
effects of multiple gestation and selective reduction on fetal outcome.
J Perinat Med 21:299-302, 1993.
16. Check
JH, Schubert B, Chase JS: Fetal outcome of triplets in a turner
mosaic. J Perinat Med 21:279-283, 1993.
17. Check
JH, Lee G, Epstein R, Vetter B: Increased rate of pre-term deliveries
in untreated women with luteal phase deficiencies - a preliminary
report. Gynecol Obstet Invest 33:183-184, 1992.
18. Check
JH, Weiss R: Letter to the editor - A critical look at hCG doubling
time. Fertil Steril 56(6):1204-1206, 1992.
19. Check
JH, Lurie D, Davies E, Vetter B: Comparison of first trimester
serum estradiol levels in aborters versus nonaborters during maintenance
of normal progesterone levels. Gynecol Obstet Invest 34:206-210,
1992.
20. Check
JH, Weiss RM, Lurie D: Analysis of serum human chorionic gonadotropin
levels in normal singleton, multiple and abnormal pregnancies.
Hum Reprod 7:1176-1180, 1992.
21. Barnea
ER, Chase JS, Check JH, Vetter BH: Estradiol deficiency associated
with spontaneous abortion even when adequate progesterone levels
are maintained. Fertility and Sterility Progress in Research
and Practice, Proceedings of the XIV World Congress on Fertility
and Sterility, Caracas, November 1992, Chapter 54, page 503-511,
1994.
22. Check
JH: The role of progesterone in supporting implantation and preventing
early pregnancy loss. Implantation and Early Pregnancy in Humans.
Edited by ER Barnea, JH Check, J Gedis Grudzinskas, T Maruo. The
Parthenon Publishing Group. Chapter 11, pages 137-160, 1994.
23. Check
JH: Letter to the editor - Predictive value of serum progesterone
levels for pregnancy outcome? Fertil Steril 62(5):1090-1091,
1994.
24. Check
JH, Vetter BH: A challenge to the concept of tubal reflux to
explain the rise and fall of cancer antigen 125 in serum during
the first trimester. Human Reproduction, 10(3):674-676, 1995.
25. Check
JH, Tarquini P, Gandy P, Lauer C: A randomized study comparing
the efficacy of reducing the spontaneous abortion rate following
lymphocyte immunotherapy and progesterone treatment vs progesterone
alone in primary aborters. Gyn Obstet. Invest., 39:257-261,
1995.
26. Peymer
M, Check JH: Incidence of infertility: etiology, pregnancy/spontaneous
abortion rates according to age of female partner. ARTA (9):79-83,
1997.
27. Dietterich
C, Check JH, Lurie D: Comparison of pregnancy outcome of natural
twin pregnancies versus multifetal pregnancies selectively reduced
to twins. Clin Exper Obstet Gynecol 24:17-18, 1997.
28. Dietterich
C, Check JH, Lurie D: A comparison of early gestational age markers
in viable twin pregnancies resulting from in vitro fertilization-embryo
transfer versus spontaneous conception with ovarian stimulation.
Clin Exper Obstet Gynecol 24:23-25, 1997.
29. Check
JH, Arwitz M, Gross J, Peymer M, Szekeres-Bartho J: Lymphocyte
immunotherapy (LI) increases serum levels of progesterone induced
blocking factor (PIBF). Am J Reprod Immunol 37:17-20, 1997.
30. Check
JH, Arwitz M, Gross J, Szekeres-Bartho J, Wu CH: Evidence that
the expression of progesterone-induced blocking factor by maternal
T-lymphocytes is positively correlated with conception. Am J
Reprod Immunol 38:6-8, 1997.
31. Kiefer
D, Check JH, Katsoff D: Evidence that oligoasthenozoospermia
may be an etiologic factor for spontaneous abortion after in vitro
fertilization-embryo transfer. Fertil Steril 68:545-548, 1997.
32. Check
JH, Ostrzenski A, Klimek R: Expression of an immunomodulatory
protein known as progesterone induced blocking factor (PIBF) does
not correlate with first trimester spontaneous abortions in progesterone
supplemented women. Am J Reprod Immunol 37:330-334, 1997.
33. Check
JH, Szekeres-Bartho J, O’Shaughnessy A: Progesterone induced
blocking factor seen in pregnancy lymphocytes soon after implantation.
Am J Reprod Immunol 35:277-280, 1996.
34. Check
JH, Fine W: Similar pregnancy and spontaneous abortion rates
after treatment with low-dose human menopausal gonadotropin versus
pure follicle stimulating hormone in women with luteal phase defects.
Clin Exp Obstet Gyn 24:5-7, 1997.
35. Katsoff
D, Kiefer D, Check M, Check JH: Oligoasthenozoospermia is not
associated with spontaneous abortions following in vivo pregnancies
contrasting with in vitro fertilization data. Arch Androl 43:203-205,
1999.
36. Wang W,
Check JH, Dietterich C, Lurie D: Effect of fibroids on cumulative
probability of pregnancy in women taking follicle maturing drugs
without assisted reproductive technology. Clin Exp Obst Gyn
28:86-88, 2001.
37. Check
JH, Nazari P, Goldberg J, Yuen W, Angotti D: A model for potential
tumor immunotherapy based on knowledge of immune mechanisms responsible
for spontaneous abortion. Med Hypoth 57:337-343, 2001.
38. Check JH,
Liss JR, Katz Y, Shucoski K: Slow rising chorionic gonadotropins
predict poor pregnancy outcome despite sonographic viability.
Clin Exp Obst Gyn 30:193-194, 2003.
|
